We speculate that the observed biphasic response of PDGFRß positive cells within the first 5 days of TBI may present a promising target to modulate clinical complications such as evolution of brain edema or improve nerve fibre regeneration13, 31. The gene discussed is PDGFRB; the disease is brain edema.